X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - 01/Jul 15:07

Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer

MONDAY, July 1, 2024 -- For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line treatment, according to a study published...

Articles similaires

Sorry! Image not available at this time

Breakthrough In Lung Cancer Treatment, Study Finds

zeenews.india.com - 01/Jul 01:08

Patients had numerically better but statistically similar five-year overall survival rates for IMRT (30.8 per cent) compared to 3D-CRT (26.6 per...

Sorry! Image not available at this time

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

drugs.com - 02/Jul 15:07

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be...

Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients

oncologynews.com.au - 25/Jun 12:37

An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...

Sorry! Image not available at this time

Survival Improves With Open Hysterectomy for Cervical Cancer

drugs.com - 28/Jun 15:03

FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally...

Sorry! Image not available at this time

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

zacks.com - 24/Jun 18:10

Bristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted treatment option for adult patients with...

New global research aims to improve survival rates for pancreatic cancer patients

oncologynews.com.au - 26/Jun 15:44

A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...

Sorry! Image not available at this time

PD-1 Non-Small Cell Lung Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:16

DelveInsight’s, “PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline Insight 2024” report provides comprehensive...

Sorry! Image not available at this time

Mediterranean Diet Ups Survival Odds After Cancer

drugs.com - 12:07

WEDNESDAY, July 3, 2024 -- The Mediterranean diet can help cancer survivors maintain their heart health and live longer, a new study says. Cancer...

Sorry! Image not available at this time

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

drugs.com - 01/Jul 15:07

MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic...

Sorry! Image not available at this time

Improved GERD Questionnaire Scores Seen With Antireflux Mucosectomy

drugs.com - 14:07

WEDNESDAY, July 3, 2024 -- For patients with refractory gastroesophageal reflux disease (GERD), those receiving antireflux mucosectomy (ARMS) have a...